Status | Study |
Completed |
Study Name: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant Condition: Hematopoietic/Lymphoid Cancer Accelerated Phase Chronic Myelogenous Leukemia Date: 2010-09-08 Interventions: Procedure: infection prophylaxis and management |
Recruiting |
Study Name: Registry of Older Patients With Cancer Condition: Chronic Myeloproliferative Disorders Cognitive/Functional Effects Date: 2010-06-03 |
Recruiting |
Study Name: Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer Condition: Chronic Myeloproliferative Disorders Leukemia Lymphoma Date: 2010-06-03 Interventions: Other: biologic sample preservation procedure |
Active, not recruiting |
Study Name: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Undifferentiated Leukemia Date: 2010-01-20 Interventions: Procedure: massage therapy Und |
Recruiting |
Study Name: Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Condition: Acute Undifferentiated Leukemia Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Date: 2009-05-09 Interventions: Other: cytology specimen collection procedure Correlative studies |
Completed |
Study Name: Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysp Date: 2009-04-29 Interventions: Drug: sunitinib malate Given P |
Active, not recruiting |
Study Name: Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia Condition: Leukemia Date: 2008-10-28 Interventions: Drug: Midostaurin (PKC412) Midostaurin was provided as 25 mg soft gelatin capsules for oral administrati |
Completed |
Study Name: Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) Condition: Leukemia Systemic Mastocytosis Date: 2007-06-26 Interventions: Drug: Ontak (Denileukin Diftitox) 9 µg/kg by vein Days 1-5 of a 21 day cycle. |
Terminated |
Study Name: Sunitinib in Treating Patients With Idiopathic Myelofibrosis Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Undifferentiated Leukemia Date: 2006-10-12 Interventions: Drug: sunitinib malate Given PO |
Active, not recruiting |
Study Name: Phase II Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia Condition: Systemic Mastocytosis, Aggressive (ASM) Leukemia, Mast Cell Date: 2005-10-03 Interventions: Drug: Midostaurin Midostaurin is a broad-spectrum protein kinase inhibitor, acting on conventional PKC i |